Latest Headlines
-
Myriad Genetics Collaborates With GSK To Improve Access To HRD Testing In 9 Countries
6/11/2024
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at improving access to homologous recombination deficiency (HRD) diagnostic testing for high-grade serous ovarian cancer (HGSOC) patients.
-
Quest Diagnostics Completes Acquisition Of Select Pathai Diagnostics' Lab Assets From Pathai, Accelerating Adoption Of AI And Digital Pathology To Speed Cancer Diagnosis
6/11/2024
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.
-
Genetic Testing On The Rise While Routine Lab Testing Stabilizes With Better Management, Report Finds
6/11/2024
The use and cost of genetic testing rose last year while routine testing remained relatively stable, according to the new 2024 Lab Trend Report from Avalon Healthcare Solutions, the world's first Lab Insights company.
-
Inter Scientific Completes Move To Expanded State-Of-The-Art Laboratory Facility In Liverpool, UK
6/11/2024
Inter Scientific, a global, industry-leading analytical testing and regulatory compliance firm, announced today that it has completed its move to a custom, 10,000 sq ft state-of-the-art facility in Liverpool, UK.
-
Next Gen Diagnostics Announces Opening Of A US Sequencing And Bioinformatics Laboratory In Cambridge, Massachusetts
6/11/2024
Next Gen Diagnostics announces its first US laboratory will be opening in Cambridge, Massachusetts, to provide low-cost, fully integrated bacterial sequencing and bioinformatics to US customers and partners.
-
Innovation In Pharmacogenomic Testing For Over A Decade
6/7/2024
Principle Diagnostics Laboratory, a leader in Pharmacogenomic (PGx) testing, proudly celebrates a decade of pioneering advancements in personalized medicine.
-
Minimally Invasive Blood Collection Could Advance Health Equity For People Experiencing Homelessness
6/6/2024
A new study demonstrates that minimally invasive blood collection devices could increase the participation of people experiencing homelessness (PEH) in public health studies and clinical research.
-
Medimab Biotherapeutics Opens Bespoke Laboratory Facilities, Created By Kadans Science Partner, At Abingdon Science Park, UK
6/6/2024
MediMab Biotherapeutics, a subsidiary of MediMabBio, Inc., a South Korea-based biotechnology firm, announces that it has opened a new state-of-the-art facility, developed by Kadans Science Partner, at Sovereign House, Abingdon Science Park, UK.
-
Dobrobut Opened Own Diagnostic Laboratories In Kyiv
6/6/2024
Dobrobut Medical Network has opened two Dobrolab diagnostic laboratories in its multidisciplinary hospitals at 3 Simi Idzykovskikh Street and 12A Mykola Bazhana Avenue.
-
Analytical Instrument Management Acquires PSI Laboratories' Assets
6/5/2024
Analytical Instrument Management (AIM) formally issues a retraction: AIM is not purchasing PSI Laboratories outright but rather their laboratory equipment only. AIM apologizes for any confusion the initial announcement caused.